Harber Asset Management LLC Acquires New Shares in HCA Healthcare, Inc. $HCA

Harber Asset Management LLC bought a new position in HCA Healthcare, Inc. (NYSE:HCA) in the second quarter, Holdings Channel.com reports. The firm bought 12,930 shares of the company’s stock, valued at approximately $5,041,000. HCA Healthcare comprises about 3.0% of Harber Asset Management LLC’s investment portfolio, making the stock its 11th biggest holding.

Several other hedge funds also recently modified their holdings of the company. Sumitomo Life Insurance Co. grew its position in HCA Healthcare by 1.0% during the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock worth $946,000 after acquiring an additional 20 shares during the last quarter. MJP Associates Inc. ADV raised its holdings in HCA Healthcare by 2.9% in the 4th quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock valued at $350,000 after buying an additional 21 shares during the last quarter. Cary Street Partners Investment Advisory LLC grew its holdings in HCA Healthcare by 7.5% during the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock worth $140,000 after acquiring an additional 21 shares during the last quarter. Anchyra Partners LLC lifted its holdings in shares of HCA Healthcare by 3.7% during the first quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock worth $278,000 after purchasing an additional 21 shares during the period. Finally, Plato Investment Management Ltd raised its position in HCA Healthcare by 0.6% during the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock worth $1,833,000 after purchasing an additional 22 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $429.08 on Friday. The stock has a market cap of $92.90 billion, a PE ratio of 14.36, a price-to-earnings-growth ratio of 1.41 and a beta of 1.10. The firm’s 50-day simple moving average is $397.16 and its 200 day simple moving average is $444.14. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. The business had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.HCA Healthcare’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period last year, the company posted $6.84 earnings per share. As a group, analysts predict that HCA Healthcare, Inc. will post 29.47 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.45%.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on HCA. Argus dropped their price target on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a research report on Monday, May 4th. Truist Financial lowered their target price on HCA Healthcare from $535.00 to $495.00 and set a “buy” rating for the company in a report on Monday, July 27th. KeyCorp cut their target price on shares of HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating on the stock in a research note on Monday, July 27th. Cantor Fitzgerald reduced their target price on HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a research note on Tuesday, July 7th. Finally, Weiss Ratings downgraded HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 9th. Fourteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $462.64.

HCA Healthcare Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.